5-alpha reductase deficiency
Dernière mise à jour 6 mars 2025
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Ajouter aux sources préférées sur Google
5-alpha reductase deficiency is a condition that affects sexual development before birth and during puberty. People with this condition are genetically male, with one X and one Y chromosome in each cell, and they have male gonads (testes). Their bodies, however, do not produce enough of a hormone called dihydrotestosterone (DHT). DHT has a critical role in male sexual development, and a shortage of this hormone disrupts the formation of the external sex organs before birth.
Description
5-alpha reductase deficiency is a condition that affects sexual development before birth and during puberty. People with this condition are genetically male, with one X and one Y chromosome in each cell, and they have male gonads (testes). Their bodies, however, do not produce enough of a hormone called dihydrotestosterone (DHT). DHT has a critical role in male sexual development, and a shortage of this hormone disrupts the formation of the external sex organs before birth.
Many people with 5-alpha reductase deficiency have external genitalia that appears female. In other cases, affected infants have male-typical external genitalia, often an unusually small penis (micropenis) and the urethra opening on the underside of the penis (hypospadias). Still other affected infants have external genitalia do not look clearly male or clearly female.
During puberty, an increase in the levels of male sex hormones leads to the development of some secondary sex characteristics, such as increased muscle mass, deepening of the voice, development of pubic hair, and a growth spurt. The penis and scrotum (the sac of skin that holds the testes) may grow larger. People with 5-alpha reductase deficiency do not develop much facial or body hair. Most affected individuals are unable to have biological children (infertile) without assisted reproduction.
Inheritance patterns
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Other names
PPSH
Pseudovaginal perineoscrotal hypospadias
Steroid 5-alpha-reductase deficiency
Related patient information and medicines
Patient information leaflet
Hypertrophie de la prostate
It occurs in less than 1 in 100 men with an enlarged prostate each year. Medicines The decision to treat with ... There are two groups of medicines that may help: Alpha-blockers. 5-alpha reductase inhibitors. Medicines do not cure the problem, nor do they usually make symptoms go completely. Alpha-blocker medicines. This can improve the flow of.
Patient information leaflet
Sang dans le sperme
Haematospermia means there is blood in the semen. Usually there are no other symptoms such as pain. The haematospermia itself does not need any treatment. Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a Inhibiteur de la 5-alpha réductase such as finasteride or dutasteride may be effective..
Patient information leaflet
Problèmes de prostate
Prostate and urethral problems can ... There are various treatments for the symptoms of BPH, including drugs such as alfuzosin/doxazosin (alpha-blockers), dutasteride/finasteride (5-alpha reductase inhibitors), oxybutinin/tolterodine/fesoterodine/darifenacin/solifenacin/trospium (antimuscarinics), mirabegron (for overactive bladder) and.
Patient information leaflet
Syndrome des jambes sans repos
Also after a time on dopamine agonists, symptoms can suddenly become much worse. If this is the case, you will need to stop or change your medication. Ligands alpha-2-delta This is another group of recommended medicines (although they do not have a licence for this condition). The two possible options are gabapentin and pregabalin. These are less.
Patient information leaflet
Thalassémie
Thalassémie est an inherited (genetic) condition affecting the blood. There are different types of thalassaemia. Depending on which type you have, thalassaemia may cause no illness at all, or may be a serious lifelong condition requiring treatment. What causes thalassaemia. The cause is an inherited (genetic) change, involving the genes which tell.
Patient information leaflet
Emphysème
Emphysème est a progressive lung condition that is a form of chronic obstructive pulmonary disease. Breathing indoor pollutants (such as fumes from heating fuel), as well as outdoor pollutants (su... Alpha-1-antitrypsin deficiency. There is a rare genetic disorder called alpha-1-antitrypsin deficiency which leads to an inherited deficiency of a.
Lectures complémentaires et références
- 5-alpha reductase deficiency; MedlinePlus, National Library of Medicine.
- Bahceci M, Ersay AR, Tuzcu A, Hiort O, Richter-Unruh A, Gokalp D. A novel missense mutation of 5-alpha reductase type 2 gene (SRD5A2) leads to severe male pseudohermaphroditism in a Turkish family. Urology. 2005 Aug;66(2):407-10. doi: 10.1016/j.urology.2005.02.021.
- Baldinotti F, Majore S, Fogli A, Marrocco G, Ghirri P, Vuerich M, Tumini S, Boscherini B, Vetri M, Scommegna S, Rinaldi R, Simi P, Grammatico P. Molecular characterization of 6 unrelated Italian patients with 5alpha-reductase type 2 deficiency. J Androl. 2008 Jan-Feb;29(1):20-8. doi: 10.2164/jandrol.107.002592. Epub 2007 Jul 3.
- Cohen-Kettenis PT. Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav. 2005 Aug;34(4):399-410. doi: 10.1007/s10508-005-4339-4.
- Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, Toralles MB, Stuchi-Perez EG, Guerra-Junior G. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2. J Mol Med (Berl). 2005 Jul;83(7):569-76. doi: 10.1007/s00109-005-0651-7. Epub 2005 Mar 16.
- Lee PA, Houk CP, Ahmed SF, Hughes IA; International Consensus Conference on Intersex organized by the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. Consensus statement on management of intersex disorders. International Consensus Conference on Intersex. Pediatrics. 2006 Aug;118(2):e488-500. doi: 10.1542/peds.2006-0738. No abstract available.
- Okeigwe I, Kuohung W. 5-Alpha reductase deficiency: a 40-year retrospective review. Curr Opin Endocrinol Diabetes Obes. 2014 Dec;21(6):483-7. doi: 10.1097/MED.0000000000000116.
- Sultan C, Lumbroso S, Paris F, Jeandel C, Terouanne B, Belon C, Audran F, Poujol N, Georget V, Gobinet J, Jalaguier S, Auzou G, Nicolas JC. Disorders of androgen action. Semin Reprod Med. 2002 Aug;20(3):217-28. doi: 10.1055/s-2002-35386.
Participez à la conversation
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.